Summary
Updated Aug 30, 2026
Carolyn C. Tang is General Counsel of Arcus Biosciences, Inc. (RCUS). 3 SEC Form 4 filings on record going back to 2024, most recently on 12 June 2026.
Recent Transactions
3Every recent SEC Form 4 transaction Carolyn C. Tang has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Carolyn C. Tang files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Juan C. Jaen - $8.07M of RCUS open-market activity in the last 12 months
- Jennifer Jarrett - $1.70M of RCUS open-market activity in the last 12 months
- Ii Robert C. Goeltz - $577K of RCUS open-market activity in the last 12 months
- Alexander Azoy - $256K of RCUS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Carolyn C. Tang?
Carolyn C. Tang is a corporate insider, tracked as General Counsel of Arcus Biosciences, Inc. (RCUS). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Carolyn C. Tang submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Where can I see all of Carolyn C. Tang's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Carolyn C. Tang and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
